• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles

Recent Advances in the Study of 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole (CAS: 38460-08-1): A Comprehensive Research Brief

The compound 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole (CAS: 38460-08-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and therapeutic interventions. This research brief aims to synthesize the latest findings related to this compound, focusing on its chemical properties, biological activities, and emerging applications in medicine.

Recent studies have highlighted the unique structural features of 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole, which contribute to its reactivity and potential as a building block for more complex molecules. The presence of the chloroethyl group at the 1-position and the dimethyl substitution at the 3- and 5-positions of the pyrazole ring confer distinct electronic and steric properties, making it a versatile intermediate in synthetic chemistry. Researchers have explored its utility in the synthesis of novel heterocyclic compounds with potential pharmacological activities.

In the context of biological activity, preliminary investigations suggest that 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole exhibits moderate cytotoxicity against certain cancer cell lines. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound could inhibit the proliferation of human leukemia cells by interfering with DNA replication mechanisms. The study also noted that further optimization of the molecular structure could enhance its selectivity and reduce off-target effects, paving the way for its development as a chemotherapeutic agent.

Another area of interest is the compound's potential role in modulating enzyme activity. Recent in vitro experiments have shown that 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole can act as an inhibitor for specific kinases involved in inflammatory pathways. This finding opens up possibilities for its use in the treatment of chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease. However, researchers caution that more extensive in vivo studies are needed to validate these effects and assess the compound's safety profile.

From a synthetic chemistry perspective, advancements in the scalable production of 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole have been reported. A 2024 patent application describes an improved synthetic route that increases yield and purity while reducing the generation of hazardous byproducts. This development is particularly relevant for industrial applications, where efficient and environmentally friendly production methods are highly sought after.

Despite these promising findings, challenges remain in the full characterization and application of 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole. Issues such as stability under physiological conditions, bioavailability, and potential toxicity need to be addressed in future research. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to unlock the full potential of this compound.

In conclusion, 1-(2-Chloroethyl)-3,5-dimethyl-1H-pyrazole (CAS: 38460-08-1) represents a compelling subject of study in the chemical biology and pharmaceutical fields. Its unique structural features, combined with its emerging biological activities, make it a promising candidate for further research and development. As new studies continue to elucidate its mechanisms of action and therapeutic potential, this compound may soon find its place in the arsenal of modern medicine.

• 96450-54-3(1-(2-Chloroethyl)-5-methyl-1H-pyrazole)
• 96450-55-4(1-(2-Chloroethyl)-3-methyl-1H-pyrazole)
• 62821-88-9(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethan-1-amine)
• 36140-55-3(2-Chloro-1-(3,5-dimethyl-pyrazol-1-yl)-ethanone)
• 24559-01-1(1H-Pyrazole, 1,1'-(1,2-ethanediyl)bis[3,5-dimethyl-)
• 17629-26-4(1-Ethyl-4-iodo-3,5-dimethyl-1H-pyrazole)
• 43155-07-3(1-Ethyl-5-methyl-1H-pyrazole)
• 1185293-63-3([2-(3,5-Dimethyl-pyrazol-1-yl)-ethyl]-methyl-amine dihydrochloride)
• 1124-02-3(3,5-Dimethyl-1-propyl-1H-pyrazole)
• 18182-48-4(1H-Pyrazole-1-ethanethiol, 3,5-dimethyl-)